Zunguo Du

1.5k total citations
61 papers, 1.0k citations indexed

About

Zunguo Du is a scholar working on Oncology, Epidemiology and Genetics. According to data from OpenAlex, Zunguo Du has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Epidemiology and 14 papers in Genetics. Recurrent topics in Zunguo Du's work include Glioma Diagnosis and Treatment (10 papers), Meningioma and schwannoma management (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Zunguo Du is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Meningioma and schwannoma management (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). Zunguo Du collaborates with scholars based in China, United States and Hungary. Zunguo Du's co-authors include Qingquan Li, Wenchao Gao, Zhiqian Hu, Zhonghua Zhao, Feng Yang, Lu Chen, Zhenyu Ma, Ying Mao, Chen Jin and Yun Bao and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Zunguo Du

58 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zunguo Du China 17 331 328 206 187 176 61 1.0k
Sílvia Regina Caminada de Toledo Brazil 23 290 0.9× 654 2.0× 154 0.7× 287 1.5× 333 1.9× 68 1.4k
Antonio Fioravanti Italy 21 296 0.9× 323 1.0× 171 0.8× 219 1.2× 285 1.6× 65 1.2k
Yonggao Mou China 17 265 0.8× 294 0.9× 72 0.3× 216 1.2× 266 1.5× 60 892
Libo Chen China 16 372 1.1× 454 1.4× 305 1.5× 196 1.0× 153 0.9× 52 1.3k
Concha López‐Ginés Spain 20 204 0.6× 340 1.0× 145 0.7× 199 1.1× 257 1.5× 66 1.1k
Changxiang Yan China 18 627 1.9× 206 0.6× 116 0.6× 112 0.6× 334 1.9× 41 1.3k
Jacob Ruzevick United States 18 485 1.5× 228 0.7× 126 0.6× 120 0.6× 370 2.1× 49 1.1k
Jochen Tuettenberg Germany 20 357 1.1× 438 1.3× 114 0.6× 265 1.4× 494 2.8× 41 1.2k
Kenji Hashimoto Japan 19 568 1.7× 289 0.9× 140 0.7× 123 0.7× 76 0.4× 54 1.1k
Pamela Becherini Italy 12 163 0.5× 609 1.9× 143 0.7× 259 1.4× 212 1.2× 18 1.0k

Countries citing papers authored by Zunguo Du

Since Specialization
Citations

This map shows the geographic impact of Zunguo Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zunguo Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zunguo Du more than expected).

Fields of papers citing papers by Zunguo Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zunguo Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zunguo Du. The network helps show where Zunguo Du may publish in the future.

Co-authorship network of co-authors of Zunguo Du

This figure shows the co-authorship network connecting the top 25 collaborators of Zunguo Du. A scholar is included among the top collaborators of Zunguo Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zunguo Du. Zunguo Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jiang, Donglang, Zhaohui Chu, You Zhang, et al.. (2025). [68Ga]Ga-NOTA-T4 ImmunoPET imaging for evaluating TROP2 expression in patients with solid tumors. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4547–4557. 1 indexed citations
3.
Wang, Jinyu, Tiantian Hu, Hao Wang, et al.. (2025). Unveiling the clinical spectrum of Porto-Sinusoidal Vascular Disorder (PSVD) with chronic HBV infection: insights from a retrospective Chinese cohort. Digestive and Liver Disease. 57(9). 1794–1801.
4.
Zhang, Xueqin, et al.. (2024). A universal multiple instance learning framework for whole slide image analysis. Computers in Biology and Medicine. 178. 108714–108714. 1 indexed citations
5.
Zhang, Jinsen, Rui Sun, Ying Liu, et al.. (2024). Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy. Nature Communications. 15(1). 10005–10005. 10 indexed citations
6.
Han, Fang, Jiahao Gao, Jing Yang, et al.. (2024). Clinically Available and Reproducible Prediction Models for IDH and CDKN2A/B Gene Status in Adult-type Diffuse Gliomas. Academic Radiology. 31(12). 5164–5174. 4 indexed citations
7.
Du, Zunguo, Shengli Lin, Wenchao Gao, et al.. (2023). Hydroxyphenylpyruvate Dioxygenase Is a Metabolic Immune Checkpoint for UTX-deficient Colorectal Cancer. Gastroenterology. 164(7). 1165–1179.e13. 7 indexed citations
8.
Yang, Zixiao, Jiajun Cai, Zunguo Du, & Jianping Song. (2022). How I do it: Surgical Resection of a Recurrent Chondromyxoid Fibroma by Micro-Endoscopic Combination Technique. Acta Neurochirurgica. 164(7). 1961–1965. 1 indexed citations
9.
Wang, Hao, Zunguo Du, Qi Huang, et al.. (2021). The superiority of [68Ga]Ga-FAPI-04 over [18F]-FDG in a case of neuroendocrine tumour with hepatic metastasis. European Journal of Nuclear Medicine and Molecular Imaging. 48(9). 3005–3006. 17 indexed citations
10.
Xu, Chenyue, et al.. (2021). High expression of DLL3 is associated with a poor prognosis and immune infiltration in invasive breast cancer patients. Translational Oncology. 14(7). 101080–101080. 15 indexed citations
11.
Zhang, Kaili, Wenwei Zhu, Shenghao Wang, et al.. (2021). Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer. Theranostics. 11(13). 6560–6572. 70 indexed citations
12.
Zhang, Jingwen, Minjie Fu, Mengli Zhang, et al.. (2021). DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker. Frontiers in Oncology. 11. 665360–665360. 12 indexed citations
13.
Chen, Gong�, S. Sun, Zunguo Du, et al.. (2019). Intra-Extracranial Primary Clear Cell Sarcoma: The First Report and Review of the Literature. World Neurosurgery. 126. e1140–e1146. 1 indexed citations
14.
Yang, Feng, Xinzhe Yu, Yun Bao, et al.. (2015). Prognostic value of Ki-67 in solid pseudopapillary tumor of the pancreas: Huashan experience and systematic review of the literature. Surgery. 159(4). 1023–1031. 61 indexed citations
16.
Jiang, Yongjian, Zunguo Du, Feng Yang, et al.. (2014). FOXP3+ Lymphocyte Density in Pancreatic Cancer Correlates with Lymph Node Metastasis. PLoS ONE. 9(9). e106741–e106741. 33 indexed citations
17.
Yue, Qi, Xin Zhang, Hongxing Ye, et al.. (2013). The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma. Journal of Neuro-Oncology. 116(2). 251–259. 61 indexed citations
18.
Gao, Wenchao, Lu Chen, Zhenyu Ma, et al.. (2013). Isolation and Phenotypic Characterization of Colorectal Cancer Stem Cells With Organ-Specific Metastatic Potential. Gastroenterology. 145(3). 636–646.e5. 102 indexed citations
19.
Chen, Lu, Danfeng Xu, Yi Gao, et al.. (2011). Effect of Donor JNK Signal Transduction Inhibition on Transplant Outcome in Brain Dead Rat Model. Inflammation. 35(1). 122–129. 9 indexed citations
20.
Lin, Min, Yun Bao, Qiong Li, et al.. (2010). [Relationship between breast cancer molecular subtypes with clinicopathological characteristics and prognosis].. PubMed. 39(6). 372–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026